Product Code: MRFR/F-B & N/5095-CR
Market Overview
Global Cognitive Health Ingredients Market is projected to register a healthy CAGR of 8.43% during the review period. The worldwide cognitive health ingredients market has encountered dynamic changes as of late determined by a few key variables. The developing mindfulness and concern in regard to cognitive health and age-related cognitive decay have filled expanded interest for items containing cognitive health ingredients. This pattern has been additionally advanced by the maturing populace in many created nations, prompting a bigger purchaser base looking for cognitive health arrangements.
Expanding consciousness of cognitive health is a vital driver behind the development of the worldwide cognitive health ingredients market. Throughout recent years, there has been a huge change in individuals' discernments in regard to mind health. With a maturing populace and expanding examples of cognitive issues like Alzheimer's illness and dementia, the significance of keeping up with cognitive capability has come to the very front of public awareness.
This elevated mindfulness is a consequence of expanded schooling and data largely spread about cognitive health. The web, online entertainment, and customary media channels play had a vital impact in spreading information about the meaning of cerebrum health. People are presently more proactive in looking for ways of improving and save their cognitive capacities, and this has converted into a flood popular for cognitive health items and ingredients.
Market Segmentation
The global cognitive health ingredients market segmentation is based on the type, such as omega-3 fatty acids, B-vitamins, vitamin E, citicoline, caffeine, adaptogens, and others.
Based on end-use the market is classified into human nutrition products, and animal nutrition products. The distribution channels segment includes direct and indirect.
Regional Analysis
The North America cognitive health ingredients market represented 34.86% in 2022 and is expected to develop with a CAGR of 8.03% during the assessed years. The US stands firm on a conspicuous footing in the North American cognitive health ingredients market because of its vigorous healthcare framework and developing familiarity with the significance of cognitive health. As of late, there has been a rising interest for cognitive health ingredients, like omega-3 unsaturated fats, cell reinforcements, and nutrients, driven by the maturing populace and worries about cognitive decay.
Europe is ready to rise to the place of the third-biggest worldwide market for food supplements, following Asia-Pacific and North America. According to information from Food Enhancements Europe, a critical 52% of European customers settle on dietary enhancements to maintain their general prosperity.
The Asia Pacific cognitive health ingredients market is encountering significant development driven by an expanded spotlight on mental prosperity. With a blossoming maturing populace and evolving ways of life, buyers in the region are turning out to be more health-cognizant, filling the interest in items that upgrade cognitive capabilities. Customary ingredients like ginseng and turmeric have acquired ubiquity for their cognitive advantages.
Market Overview
Key Companies in the Cognitive Health Ingredients market include Kemin Industries, Inc. (US), Nexira (France), Arla Food Ingredients Group (Denmark), Aurea Biolabs (India), Bioriginal Food & Science Corp (Canada), Biotropics Malaysia Berhad (Malaysia), Natural Factors Nutritional Products Ltd (Canada), NOW Foods (US), Intelligent Labs (UK), and BASF SE (Germany).
TABLE OF CONTENTS
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 14
- 1.1.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY TYPE 16
- 1.1.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY END-USE 17
- 1.1.3 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY DISTRIBUTION CHANNEL 18
- 1.1.4 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY REGION 19
2 MARKET INTRODUCTION 20
- 2.1 DEFINITION 20
- 2.2 SCOPE OF THE STUDY 20
- 2.3 MARKET STRUCTURE 21
- 2.4 KEY BUYING CRITERIA 21
3 RESEARCH METHODOLOGY 22
- 3.1 RESEARCH PROCESS 22
- 3.2 PRIMARY RESEARCH 23
- 3.3 SECONDARY RESEARCH 24
- 3.4 MARKET SIZE ESTIMATION 24
- 3.5 TOP DOWN & BOTTOM-UP APPROACH 25
- 3.6 FORECAST MODEL 26
- 3.7 LIST OF ASSUMPTIONS 27
4 MARKET DYNAMICS 28
- 4.1 INTRODUCTION 28
- 4.2 DRIVERS 29
- 4.2.1 INCREASING AWARENESS OF COGNITIVE HEALTH 29
- 4.2.2 GROWING AGING POPULATION WORLDWIDE 29
- 4.2.3 DRIVERS IMPACT ANALYSIS 30
- 4.3 RESTRAINTS 30
- 4.3.1 STRINGENT REGULATORY REQUIREMENTS AND APPROVALS IN THE COGNITIVE HEALTH INGREDIENTS 30
- 4.3.2 CONCERNS REGARDING POTENTIAL SIDE EFFECTS OR SAFETY ISSUES OF CERTAIN INGREDIENTS LIMIT ADOPTION 31
- 4.3.3 RESTRAINTS IMPACT ANALYSIS 31
- 4.4 OPPORTUNITIES 32
- 4.4.1 GROWING DEMAND FOR PERSONALIZED NUTRITION 32
- 4.5 IMPACT OF COVID-19 ON GLOBAL ECONOMY 32
- 4.6 IMPACT OF COVID-19 ON THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 33
- 4.7 SUPPLY CHAIN IMPACT 34
- 4.7.1 IMPACT ON MANUFACTURER 34
- 4.7.2 IMPACT ON RAW MATERIAL SUPPLIER 34
- 4.7.3 IMPACT ON DISTRIBUTION/LOGISTICS 34
5 MARKET FACTOR ANALYSIS 35
- 5.1 SUPPLY/VALUE CHAIN ANALYSIS 35
- 5.1.1 RAW MATERIALS SUPPLIERS 35
- 5.1.2 MANUFACTURING & PACKAGING 35
- 5.1.3 DISTRIBUTION & SALES CHANNEL 36
- 5.1.4 RETAILERS AND END-USERS 36
- 5.2 PORTER'S FIVE FORCES MODEL 36
- 5.2.1 THREAT OF NEW ENTRANTS 37
- 5.2.2 BARGAINING POWER OF SUPPLIERS 37
- 5.2.3 BARGAINING POWER OF BUYERS 37
- 5.2.4 THREAT OF SUBSTITUTES 37
- 5.2.5 INTENSITY OF RIVALRY 37
6 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY TYPE 38
- 6.1 OVERVIEW 38
- 6.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE, MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030 40
- 6.2.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE: MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030 40
7 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY END-USE 41
- 7.1 OVERVIEW 41
- 7.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE, MARKET ESTIMATES & FORECAST BY END-USE, 2019-2030 42
- 7.2.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE: MARKET ESTIMATES & FORECAST BY END-USE, 2019-2030 42
8 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY DISTRIBUTION CHANNEL 43
- 8.1 OVERVIEW 43
- 8.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE, MARKET ESTIMATES & FORECAST BY DISTRIBUTION CHANNEL, 2019-2030 44
- 8.2.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE: MARKET ESTIMATES & FORECAST BY DISTRIBUTION CHANNEL, 2019-2030 44
9 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY REGION 45
- 9.1 OVERVIEW 45
- 9.2 NORTH AMERICA 47
- 9.2.1 U.S. 49
- 9.2.2 CANADA 50
- 9.2.3 MEXICO 51
- 9.3 EUROPE 53
- 9.3.1 GERMANY 56
- 9.3.2 FRANCE 57
- 9.3.3 UK 58
- 9.3.4 ITALY 59
- 9.3.5 SPAIN 60
- 9.3.6 REST OF EUROPE 61
- 9.4 ASIA PACIFIC 62
- 9.4.1 CHINA 65
- 9.4.2 INDIA 66
- 9.4.3 JAPAN 67
- 9.4.4 AUSTRALIA & NEW ZEALAND 68
- 9.4.5 REST OF ASIA PACIFIC 69
- 9.5 SOUTH AMERICA 70
- 9.5.1 BRAZIL 72
- 9.5.2 ARGENTINA 73
- 9.5.3 REST OF SOUTH AMERICA 74
- 9.6 MIDDLE EAST & AFRICA 76
- 9.6.1 GCC COUNTRIES 78
- 9.6.2 TURKEY 79
- 9.6.3 NORTHERN AFRICA 80
- 9.6.4 SOUTHERN AFRICA 81
10 COMPETITIVE LANDSCAPE 83
- 10.1 COMPETITIVE OVERVIEW 83
- 10.2 COMPETITIVE BENCHMARKING 83
- 10.3 MAJOR PLAYERS IN THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 84
- 10.4 LEADING PLAYERS IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 84
- 10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 85
- 10.5.1 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL 85
- 10.5.2 EXPANSION/ACQUISITION/ PARTNERSHIP 85
11 COMPANY PROFILES 86
- 11.1 KEMIN INDUSTRIES, INC. 86
- 11.1.1 COMPANY OVERVIEW 86
- 11.1.2 FINANCIAL OVERVIEW 86
- 11.1.3 PRODUCTS OFFERED 86
- 11.1.4 KEY DEVELOPMENTS 86
- 11.1.5 SWOT ANALYSIS 87
- 11.1.6 KEY STRATEGIES 87
- 11.2 NEXIRA 88
- 11.2.1 COMPANY OVERVIEW 88
- 11.2.2 FINANCIAL OVERVIEW 88
- 11.2.3 PRODUCTS OFFERED 88
- 11.2.4 KEY DEVELOPMENTS 88
- 11.2.5 SWOT ANALYSIS 89
- 11.2.6 KEY STRATEGIES 89
- 11.3 ARLA FOOD INGREDIENTS GROUP 90
- 11.3.1 COMPANY OVERVIEW 90
- 11.3.2 FINANCIAL OVERVIEW 90
- 11.3.3 PRODUCTS OFFERED 91
- 11.3.4 KEY DEVELOPMENTS 91
- 11.3.5 SWOT ANALYSIS 91
- 11.3.6 KEY STRATEGIES 91
- 11.4 AUREA BIOLABS 92
- 11.4.1 COMPANY OVERVIEW 92
- 11.4.2 FINANCIAL OVERVIEW 92
- 11.4.3 PRODUCTS/SERVICES OFFERED 92
- 11.4.4 KEY DEVELOPMENTS 92
- 11.4.5 SWOT ANALYSIS 93
- 11.4.6 KEY STRATEGIES 93
- 11.5 BIORIGINAL FOOD & SCIENCE CORP 94
- 11.5.1 COMPANY OVERVIEW 94
- 11.5.2 FINANCIAL OVERVIEW 94
- 11.5.3 PRODUCTS/SERVICES OFFERED 94
- 11.5.4 KEY DEVELOPMENTS 94
- 11.5.5 SWOT ANALYSIS 95
- 11.5.6 KEY STRATEGIES 95
- 11.6 BIOTROPICS MALAYSIA BERHAD 96
- 11.6.1 COMPANY OVERVIEW 96
- 11.6.2 FINANCIAL OVERVIEW 96
- 11.6.3 PRODUCTS/SERVICES OFFERED 96
- 11.6.4 KEY DEVELOPMENTS 96
- 11.6.5 SWOT ANALYSIS 97
- 11.6.6 KEY STRATEGIES 97
- 11.7 NATURAL FACTORS NUTRITIONAL PRODUCTS LTD 98
- 11.7.1 COMPANY OVERVIEW 98
- 11.7.2 FINANCIAL OVERVIEW 98
- 11.7.3 PRODUCTS/SERVICES OFFERED 98
- 11.7.4 KEY DEVELOPMENTS 98
- 11.7.5 SWOT ANALYSIS 99
- 11.7.6 KEY STRATEGIES 99
- 11.8 NOW FOODS 100
- 11.8.1 COMPANY OVERVIEW 100
- 11.8.2 FINANCIAL OVERVIEW 100
- 11.8.3 PRODUCTS/SERVICES OFFERED 100
- 11.8.4 KEY DEVELOPMENTS 100
- 11.8.5 SWOT ANALYSIS 101
- 11.8.6 KEY STRATEGIES 101
- 11.9 INTELLIGENT LABS 102
- 11.9.1 COMPANY OVERVIEW 102
- 11.9.2 FINANCIAL OVERVIEW 102
- 11.9.3 PRODUCTS OFFERED 102
- 11.9.4 KEY DEVELOPMENTS 102
- 11.9.5 SWOT ANALYSIS 103
- 11.9.6 KEY STRATEGIES 103
- 11.10 BASF SE 104
- 11.10.1 COMPANY OVERVIEW 104
- 11.10.2 FINANCIAL OVERVIEW 104
- 11.10.3 PRODUCTS OFFERED 105
- 11.10.4 KEY DEVELOPMENTS 105
- 11.10.5 SWOT ANALYSIS 105
- 11.10.6 KEY STRATEGIES 106
12 APPENDIX 107